Literature DB >> 16934681

Lutein effect on retina and hippocampus of diabetic mice.

María Muriach1, Francisco Bosch-Morell, George Alexander, Rune Blomhoff, Jorge Barcia, Emma Arnal, Inma Almansa, Francisco J Romero, María Miranda.   

Abstract

Oxidative stress markers and functional tests were studied to confirm early biochemical and functional changes in retina and hippocampus of diabetic mice. The effects of lutein treatment were also tested. Mice were induced diabetic by alloxan injection and divided into subgroups: control, control+lutein, diabetic, diabetic+lutein, diabetic+insulin, and diabetic+insulin+lutein. Treatments started on Day 4 after alloxan injection and animals were sacrificed on Day 14. Malondialdehyde and glutathione concentrations and glutathione peroxidase activity were measured as oxidative stress markers. The following functional tests for retina and hippocampus were performed: electroretinogram and Morris water maze test. NFkappaB activity was also measured. Oxidative stress and NFkappaB activity increase in the retina and hippocampus after 15 days of diabetes. Impairment of the electroretinogram and a correlation between latencies of the water maze test and glycated hemoglobin (HbA1c) levels were observed. Lutein prevented all these changes even under hyperglycemic conditions. Retina appears to be affected earlier than hippocampus by diabetes-induced oxidative stress. Although a proper glycemic control is desirable in preventing the development of diabetic complications, it is not sufficient to prevent them completely. Lutein could be an appropriate coadjuvant treatment for the changes observed in this study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934681     DOI: 10.1016/j.freeradbiomed.2006.06.023

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  34 in total

1.  Macular pigment optical density is positively associated with academic performance among preadolescent children.

Authors:  Sasha M Barnett; Naiman A Khan; Anne M Walk; Lauren B Raine; Christopher Moulton; Neal J Cohen; Arthur F Kramer; Billy R Hammond; Lisa Renzi-Hammond; Charles H Hillman
Journal:  Nutr Neurosci       Date:  2017-05-23       Impact factor: 4.994

2.  Neuroprotective Effects of Rutin in Streptozotocin-Induced Diabetic Rat Retina.

Authors:  Mohammad Shamsul Ola; Mohammed M Ahmed; Rehan Ahmad; Hatem M Abuohashish; Salim S Al-Rejaie; Abdullah S Alhomida
Journal:  J Mol Neurosci       Date:  2015-05-01       Impact factor: 3.444

Review 3.  Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications.

Authors:  Lawrence P Reagan
Journal:  Exp Neurol       Date:  2011-02-12       Impact factor: 5.330

Review 4.  The Therapeutic Role of Carotenoids in Diabetic Retinopathy: A Systematic Review.

Authors:  Mohammad Fathalipour; Hadis Fathalipour; Omid Safa; Peyman Nowrouzi-Sohrabi; Hossein Mirkhani; Soheil Hassanipour
Journal:  Diabetes Metab Syndr Obes       Date:  2020-07-03       Impact factor: 3.168

5.  Lutein protects RGC-5 cells against hypoxia and oxidative stress.

Authors:  Suk-Yee Li; Amy C Y Lo
Journal:  Int J Mol Sci       Date:  2010-05-11       Impact factor: 5.923

6.  Lutein prevents the effect of high glucose levels on immune system cells in vivo and in vitro.

Authors:  M Muriach; F Bosch-Morell; E Arnal; G Alexander; R Blomhoff; F J Romero
Journal:  J Physiol Biochem       Date:  2008-06       Impact factor: 4.158

7.  Lutein prevents cataract development and progression in diabetic rats.

Authors:  Emma Arnal; María Miranda; Inmaculada Almansa; María Muriach; Jorge M Barcia; Francisco J Romero; Manuel Diaz-Llopis; Francisco Bosch-Morell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-03       Impact factor: 3.117

8.  Carotenoid derived aldehydes-induced oxidative stress causes apoptotic cell death in human retinal pigment epithelial cells.

Authors:  Nilesh M Kalariya; Kota V Ramana; Satish K Srivastava; Frederik J G M van Kuijk
Journal:  Exp Eye Res       Date:  2007-09-29       Impact factor: 3.467

Review 9.  Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications.

Authors:  Ana Gabriela Murillo; Maria Luz Fernandez
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

10.  Gallic acid and p-coumaric acid attenuate type 2 diabetes-induced neurodegeneration in rats.

Authors:  Adel Abdel-Moneim; Ahmed I Yousef; Sanaa M Abd El-Twab; Eman S Abdel Reheim; Mohamed B Ashour
Journal:  Metab Brain Dis       Date:  2017-06-02       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.